News

Filter by:
Filter by:
Lab
Topics

Whitehead Institute scientists have developed a rapid, inexpensive drug-screening method that could be used to target diseases that until now have stymied drug developers, such as Parkinson’s disease.  This technique uses baker’s yeast to synthesize and screen the molecules, cutting target discovery and preliminary testing time to a matter of weeks.

Researchers at Whitehead Institute for Biomedical Research have identified a protein in multiple myeloma cells, called DEPTOR, that indirectly activates a signaling pathway commonly turned on in cancer cells. Known as the PI3K/PTEN/Akt pathway, this signaling pathway controls cell survival, and when altered, keeps cancer cells from dying.